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Objective: To evaluate whether the methanol extract of Codium fragile (MECF) regu-
lates tumor necrosis factor-a (TNF-a)-induced invasion of human breast cancer MDA-
MB-231 cells by suppressing matrix metalloproteinase-9 (MMP-9).
Methods: Reverse transcription-polymerase chain reaction (RT-PCR) and western blot
analysis were performed to analyze the expression of MMP-9 and nuclear factor-kB (NF-
kB) subunits, p65 and p50, and IkB in MDA-MB-231 cells. 3-(4,5-Dimethyl-
2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was used for cell
viability. MMP-9 activity and invasion were measured by gelatin zymography and a
matrigel invasion assay, respectively. NF-kB activity was measured by an electrophoretic
mobility shift assay and luciferase activity.
Results: MECF had no effect on cell viability up to a concentration of 100 mg/mL in
human breast cancer MDA-MB-231 cells regardless of the presence of TNF-a. MDA-
MB-231 cells that were stimulated with TNF-a showed a marked increase of invasion
compared to the untreated control, whereas pretreatment with MECF downregulated the
TNF-a-induced invasion of MDA-MB-231 cells. Additionally, zymography, western blot
analysis, and RT-PCR conﬁrmed that MECF decreased TNF-a-induced MMP-9
expression and activity which is a key regulator for cancer invasion. According to an
electrophoretic morbidity shift assay, pretreatment with MECF in MDA-MB-231 cells
signiﬁcantly decreased the TNF-a-induced DNA-binding activity of NF-kB, which is an
important transcription factor for regulating cancer invasion-related genes such as MMP-
9. Furthermore, treatment with MECF sustained the expression of p65 and p50 in
response to TNF-a in the cytosolic compartment. The luciferase assay demonstrated that
MECF attenuated TNF-a-induced NF-kB luciferase activity.
Conclusion: MECF exhibited its anti-invasive capability by downregulating TNF-a-
induced MMP-9 expression, resulting from the suppression of NF-kB activity in the
human breast cancer cell line MDA-MB-231.1. Introduction
Metastasis and invasion are key factors that determine the
malignant behavior of cancer cells. In particular, extracellular
proteinases are essential for the metastasis and invasion pro-
cesses that degrade the components of the extracellular matrix
(ECM) and facilitate the disconnection of intercellular adhesions
and separation of single cells from solid tumor tissue torticle under the CC BY-NC-ND license (http://
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(MMPs) are important zinc-dependent endopeptidases respon-
sible for the degradation of major components of ECM,
including type IV and V gelatin, and collagen. Thus, its role is
closely related to the metastasis and invasion of cancer cells [2].
Among the MMP family, which consists of 24 members, MMP-
9 is known to be signiﬁcantly upregulated in almost all tumor
types [3]. Furthermore, MMP-9 expression positively correlates
with cancer stage, grade, and prognosis [4]. Several studies have
shown that cancer cells that were attributable to metastasis to
distant organs, including the lungs, liver, lymph nodes, and
adrenal medulla expressed high levels of MMP-9 [3,5]. This
suggests that MMP-9 is not only important in identifying inva-
sion symptoms and its diagnosis, but also a promising strategy to
prevent cancer invasion and metastasis. Therefore, MMP-9
expression may prove an important therapeutic target for pre-
venting the invasion and metastasis of a broad-spectrum of
cancers.
Tumor necrosis factor alpha (TNF-a) plays a key role in
tumorigenesis by enhancing the growth of cancer and its sur-
vival, invasion, and metastasis, resulting in a direct network of
MMP-9 production [6,7]. After TNF-a binds to its receptor,
adapter molecules are recruited to the conformationally-
changed receptor, allowing the initiation of the intracellular
signaling pathways including nuclear factor-kB (NF-kB) [8]. In
particular, NF-kB is not only well known to contribute to
cancer invasion and resistance to chemotherapy, but also to be
constitutively activated in various cancer [9,10]. Until cells
receive an appropriate stimulus, NF-kB complexes are
sequestered by binding with the inhibitor kappa B (IkB) in the
cytoplasm, forming a transcriptionally inactive stage [11]. In
response to various stimuli such as TNF-a, IkB is
phosphorylated and degraded, resulting in the liberation of
NF-kB, which allows NF-kB to accumulate in the nucleus and
thus activates the expression of target genes such as MMP-9
[12,13]. Therefore, the inhibition of NF-kB can be considered
as an adjuvant approach to suppress MMP-9 expression and
thus prevent cancer invasion and metastasis.
Marine macroalgae are an inexhaustible source of unique
natural products with pharmacological activities, which produce a
vast array of bioactive secondary metabolites [14]. The secondary
metabolites from marine macroalgae were recently demonstrated
to possess anti-tumor and anti-inﬂammatory capabilities [15].
Codium fragile (C. fragile) is a green macroalgae belonging to
family Codiaceae, which has demonstrated anti-cancer activity
against various cancers. Previously, Noda et al, reported that the
C. fragile extract exhibited a 43.4% cancer growth inhibition rate
in mice [16]. Furthermore, clerosterol from C. fragile enhanced
cytotoxicity in human melanoma cells [17]. Additionally,
aqueous extracts of C. fragile exhibited strong cytotoxic
activities against the CT26 mouse colon carcinoma cell line
and carotenoids from C. fragile induced apoptosis in human
leukemia cells [18,19]. However, no study has investigated the
effect of C. fragile on MMP-9 expression and activity or inva-
sion and metastasis in TNF-a- stimulated cancer cells.
In the present study, we examined effects of the methanol
extract of C. fragile (MECF) on MMP-9 expression and ac-
tivity in TNF-a-stimulated MDA-MB-231 human breast cancer
cells. Our results indicate that MECF suppressed TNF-a-
induced MMP-9 expression and activity by downregulating the
NF-kB pathway, leading to the inhibition of MDA-MB-231
invasion.2. Materials and methods
2.1. Preparation of C. fragile
MECF was purchased from Jeju Hi-Tech Industry Devel-
opment Institute (Jeju, Republic of Korea). In brief, C. fragile
was collected along the Jeju Island coast (Republic of Korea).
Fresh C. fragile was washed three times with tap water to
remove salt, epiphyte, and sand on the surface of the samples
before storage at −20 C. The frozen samples were lyophilized
and homogenized using a grinder before extraction. The dried
powder was extracted with 80% methanol and evaporated in
the vacuum. The extract was ﬁltered through 0.45 mm ﬁlter and
the ﬁltrate was freeze-dried (yield, approximately 4.1 g) and
stored at 4 C. The dried ﬁltered through 0.22 mm ﬁlter before
use.
2.2. Antibodies and reagents
Antibodies against p50, p65, IkB, b-actin, and nucleolin were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Antibody against MMP-9 was obtained from Cell Signaling
(Beverly, MA). Peroxidase-labeled donkey anti-rabbit and sheep
anti-mouse immunoglobulin, and TNF-a were purchased from
KOMA Biotechnology (Seoul, Republic of Korea). 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
was obtained from Sigma (St. Louis, MO). RPMI 1640 medium,
fetal bovine serum (FBS), and antibiotics mixture were pur-
chased from WelGENE (Daegu, Republic of Korea).
2.3. Cell culture and viability
Human breast cancer cell line MDA-MB-231 was obtained
from the American Type Culture Collection (Manassas, VA).
The cells were cultured at 37 C in a 5% CO2-humidiﬁed
incubator and maintained in RPMI 1640 medium containing
10% heat-inactivated FBS and 1% antibiotics mixture. The cells
were seeded at 5 × 104 cells/ml, incubated, and then treated with
the indicated concentrations of MECF in the presence or absence
of TNF-a (20 ng/mL). Following 24-h incubation, the viability
was measured by MTT assay.
2.4. Invasion assay
Invasion assay was performed into 24-well chambers
(Corning, Corning, NY) coated with matrigel in serum-free
RPMI 1640 medium. Precoated ﬁlters (6.5 mm in diameter
and 8 mm pore size) were rehydrated and the cells (5 × 104 cells/
mL) in medium with or without MECF in the presence of TNF-a
(20 ng/mL) were seeded into the upper part of each chamber.
Following 24-h incubation, non-migrated cells were removed
using cotton swabs and migrated cells were ﬁxed and stained
with 0.125% Coomassie Blue in a methanol:acetic acid: distilled
water mixture (15:10:45, v/v/v). Invading cells were counted
under a light microscope.
2.5. Gelatin zymography assay
Cultured MDA-MB-231 cells were collected and washed
three times with serum-free RPMI 1640 medium. The cells
were seed at 3 × 105 cells/mL in serum-free RPMI 1640
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(20 ng/mL). The medium was collected and electrophoresed on
a polyacrylamide gel containing 0.1% (w/v) gelatin as a sub-
strate. The gel was washed at room temperature for 10 min, 3
times with 2.5% Triton X-100 washing buffer, and subse-
quently incubated at 37 C for 24 h in reaction buffer (0.2%
Brij, 35.5 mM CaCl2, 1 mM NaCl, and 50 mM Tris, pH 7.4).
The gel was stained for 1 h with 0.25% Coomassie Blue in 10%
acetic acid/40% methanol and then destained with 10% acetic
acid/40% methanol for 1 h. Areas of protease activity appeared
as clear bands.
2.6. RNA extraction and reverse transcriptase-
polymerase chain reaction (RT-PCR)
Total RNA was extracted using Easy-Blue reagent (iNtRON
Biotechnology, Sungnam, Korea). RNA concentration and
purity were measured by absorbance at 260 nm/280 nm. Genes
of interest were ampliﬁed from cDNA that was synthesized
from 1 mg total RNA using MMLV reverse transcriptaseMECF ( g/mL)
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Figure 1. Effects of MECF on the viability and invasion activity of MDA-MB
(A) MDA-MB-231 cells (5 × 104 cells/mL) were cultured in 24-well plates and
presence or absence 20 ng/mL TNF-a for 24 h. Cell viability was determined
transwells were coated with matrigel. MDA-MB-231 cells were cultured in se
presence or absence of TNF-a (20 ng/mL) for 24 h. The cells that passed throug
in ethanol. *P < 0.05 vs. TNF-毩-treated group.(Bioneer Corp., Daejeon, Korea). Primers for glyceraldenhyde-
3-phosphate dehydrogenase (GAPDH) (sense 50-CCA CCC
ATG GCA AAT TCC ATG CA-30 and antisense 50-TCT AGA
CGG CAG GTC AGG TCC ACC-30) and MMP-9 (sense 50-
CCT GGA GAC CTG AGA ACC AAT CT-30 and antisense 50-
CCA CCC GAG TGT AAC CAT AGC-30) were used. PCR
was performed at 94 C for 5 min followed 27 cycles of 94 C
for 30 s, annealing temperature (GAPDH at 62 C and MMP-9
at 59 C) for 30 s, 72 C for 30 s followed via ﬁnal extension at
72 C for 5 min. Following ampliﬁcation, PCR products were
separated 1% agarose gels and visualized using ethidium bro-
mide ﬂuorescence.
2.7. Western blot analysis
Total protein extracts were prepared by a PRO-PREP
protein extraction kit (iNtRON Biotechnology). Brieﬂy,
MDA-MB-231 cells were harvested, washed twice with ice-
cold PBS, and gently lysed for 30 min in 100 mL ice-cold
PRO-PREP lysis buffer. The lysates were centrifuged at100
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Figure 2. Effects of MECF on TNF-a induced MMP-9 expression and
activity in MDA-MB-231 cells.
(A) MDA-MB-231 cells were treated with the indicated concentrations (0–
100 mg/mL) of MECF for 1 h before treatment with 20 ng/mL TNF-a in the
absence of FBS for 24 h. The conditioned medium was collected from
cultures and subjected to gelatin zymography. (B) Equal amounts of cell
lysates were resolved on SDS-polyacrylamide gels, transferred to nitro-
cellulose membranes, and probed with antibodies against MMP-9. (C)
MDA-MB-231 cells were incubated with the indicated concentrations (0–
100 mg/mL) of MECF for 1 h before treatment with TNF-a (20 ng/mL) for
6 h. Total RNA was isolated, and RT-PCR analysis of MMP-9 was per-
formed. GAPDH and b-actin were used as internal controls for RT-PCR
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protein concentrations were determined using a Bio-Rad pro-
tein assay kit (Bio-Rad, Hercules, CA). The samples were
stored at −80 C or immediately used for Western blot anal-
ysis. The proteins were separated on SDS-polyacrylamide gels
and transferred to nitrocellulose membranes (Schleicher &
Schuell, Keene, NH). Proteins were detected by an enhanced
chemiluminescence detection system (Amersham, Arlington
Heights, IL).
2.8. Electrophoretic mobility shift assay (EMSA)
The cytoplasmic and nuclear proteins were prepared using
the NE-PER nuclear and cytoplasmic extraction reagents
(Pierce, Rockford, IL). DNA-binding activity of NF-kB was
performed using nuclear extracts. Synthetic complementary NF-
kB-binding oligonucleotides (50-AGT TGA GGG GAC TTT
CCC AGG C-30; Santa Cruz Biotechnology) were biotinylated
using biotin 30-end DNA labeling kit (Pierce) and annealed for
30 min at 37 C according to the manufacturer's instructions.
Labeled oligonucleotides, 10 mg nuclear protein extracts, 100 ng
poly[deoxyinosinic-deoxycytidylic] acid, and LightShiftTM
chemiluminescent EMSA kit mixture were then incubated for
30 min at room temperature. The samples were loaded onto
native 4% polyacrylamide gels pre-electrophoresed for 1 h in
0.5 × Tris-borate/EDTA (TBE) buffer and transferred onto a
positively charged nylon membrane (HybondTM-N+) in
0.5 × TBE buffer at 100 V for 1 h on ice. Transferred DNAs
were cross-linked on the membrane at 120 mJ/cm2 and detected
using horseradish peroxidase-conjugated streptavidin according
to the manufacturer's instructions.
2.9. Luciferase activity assay
NF-kB reporter construct was purchased from Clontech (Palo
Alto, CA). In brief, MDA-MB-231 cells were seeded onto 6-
well plates at a density of 3 × 105 cells/mL and incubated
overnight. The cells were transfected with NF-kB reporter
construct by Lipofectamine method. After 6-h incubation, the
cells were washed and cultured in RPMI 1640 containing 10%
FBS with MECF (100 mg/mL) in the presence or absence of
TNF-a (20 ng/mL). The cells were lysed with lysis buffer
(2 mM DTT, 150 mM NaCl, 20 mM Tris–HCl, and 1% Triton
X-100) at 24 h. The lysate was mixed with luciferase activity
reagent, and luminescence was measured using a GLOMAX
luminometer (Promega, Madison, WI) and intensity of lumi-
nescence was obtained using an image analyzer.
2.10. Statistical analysis
The images were visualized with Chemi-Smart 2000 (Vil-
berLourmat, Marine, Cedex, France). Images were captured
using Chemi-Capt (VilberLourmat) and transported into Photo-
shop. All bands were shown a representative obtained in three
independent experiments and quantiﬁed by Scion Imaging
software (http://www.scioncorp.com). Statistical analyses were
conducted using SigmaPlot software (version 12.0). Values were
presented as mean ± standard error (S.E.). Signiﬁcant differences
between the groups were determined using the unpaired one-
way ANOVA test by Bonferroni's test. Statistical signiﬁcance
was regarded at P < 0.05.3. Results
3.1. MECF inhibits TNF-a-induced cell invasion
In order to measure whether MECF inﬂuences cell viability,
we treated MDA-MB-231 cells with various concentrations of
MECF in the presence or absence of TNF-a for 24 h and then
performed MTT assay. Exposure up to 100 mg/mL MECF had
no effect on cell viability in the presence or absence of TNF-a
(Figure 1A). Furthermore, to examine the inhibitory effects of
MECF on the invasion of MDA-MB-231 cells, we performed an
invasion assay using matrigel-coated transwells. TNF-a-stimu-
lated MDA-MB-231 cells showed a marked increase of invasion
compared to that of the untreated control; however, pretreatment
with MECF downregulated the TNF-a-induced invasion of the
cells (Figure 1B). Therefore, these results indicate that MECF
inhibited TNF-a-induced invasion in MDA-MB-231 cells
without any direct cytotoxicity.
3.2. MECF downregulates TNF-a-induced MMP-9
activity and expression
MMP-9 is a key enzyme for the invasion and metastasis of
cancer cells. Subsequently, in order to evaluate whether MECFand Western blot analysis, respectively.
mL
Figure 3. Effect of MECF on TNF-a-induced NF-kB activity in MDA-MB-231 cells. MDA-MB-231 cells were treated with MECF (100 mg/mL) in the
presence of TNF-a (20 ng/mL) and nuclear and cytosolic extracts were extracted.
(A) The nuclear extracts were prepared after 30 min, and NF-kB binding to its DNA promoter region in the extract was measured using an EMSA. (B)
Levels of p65, p50, and IkB in the nuclear (top) and cytosolic (bottom) extracts were determined by Western blot analysis at 30 min b-Actin and nucleolin
were used as cytosolic and nuclear internal controls for the Western blot analysis. (C) MDA-MB-231 cells were transfected with the NF-kB promoter-
containing reporter vector and treated with MECF (100 mg/mL) in the presence of TNF-a (20 ng/mL). Luciferase activity was measured by a lumin-
ometer. (*P < 0.05 vs. TNF-a-treated group).
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zymography, Western blot analysis, and RT-PCR. According to
the zymography data, TNF-a-treated MDA-MB-231 cells
signiﬁcantly increased the gelatin-degrading activity of MMP-9
whereas MECF-pretreated cells decreased the TNF-a-induced
MMP-9 activity in a concentration-dependent manner
(Figure 2A). In addition, the Western blot analysis revealed that
stimulation with TNF-a resulted in a remarkable upregulation of
MMP-9 expression in the protein level compared to that of the
untreated control; however, pretreatment with MECF inhibited
TNF-a-induced MMP-9 expression (Figure 2B). In accordance
with the suppression of MMP-9 activity and protein expression
of MECF, RT-PCR analysis also showed that MECF signiﬁ-
cantly downregulated TNF-a-induced MMP-9 expression in
MDA-MB-231 cells (Figure 2C). These data suggests that
MECF inhibited MMP-9 expression and activity, leading to the
suppression of invasion of MDA-MB-231 cells.
3.3. MECF suppresses TNF-a-induced NF-kB
To further examine whether MECF suppresses MMP-9
expression by inhibiting NF-kB, we determined the speciﬁc
DNA-binding activity of NF-kB. According to EMSA data, the
TNF-a-induced DNA-binding activity of NF-kB at 30 min was
5-fold to that of the untreated control; however, pretreatmentwith MECF signiﬁcantly decreased TNF-a-induced NF-kB ac-
tivity (Figure 3A). Consistent with EMSA data, Western blot
analysis also showed that treatment with TNF-a increased p65
and p50 levels in the nuclear compartment, whereas MECF
attenuated p65 and p50 levels in the nuclear extract (Figure 3B).
In a parallel experiment, TNF-a decreased p65, p50, and IkB
expression in the cytosol which suggests that TNF-a induces
nuclear translocation of p65 and p50 by degrading IkB. How-
ever, treatment with MECF sustained p65, p50, and IkB in
response to TNF-a in the cytosolic compartment. Moreover, we
examined NF-kB promoter activity using transiently transfected
MDA-MB-231 cells with a luciferase reporter vector consisting
of NF-kB binding sites. The TNF-a-stimulated MDA-MB-
231 cells showed approximately a 7-fold increases in NF-kB
luciferase activity when compared to the untreated control
(Figure 3C). Interestingly, pretreatment with MECF decreased
TNF-a-induced NF-kB luciferase activity. Taken together, these
results indicated that MECF attenuated TNF-a-induced NF-kB
activity, resulting in MMP-9 gene expression.
4. Discussion
Recent studies reported that the C. fragile extract exhibits
diverse pharmacological properties such as anti-edema, anti-
viral, anti-bacterial, anti-allergic, anti-protozoal, and anti-
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the anti-invasive properties of the C. fragile extract. Therefore,
we investigated the anti-invasive activity of MECF in MDA-
MB-231 cells. The present study showed that MECF suppressed
TNF-a-induced MMP-9 expression and activity by inhibiting
NF-kB activity, resulting in the anti-invasion of MDA-MB-
231 cells.
Numerous reports have demonstrated that various MMPs are
directly implicated in the cancer cell invasion process and
therefore promote metastasis [1,3]. In particular, MMP-9 is
implicated in carcinogenesis as a key enzyme that is overex-
pressed in different types of malignant cancers, and its expres-
sion and activity are associated with the aggressiveness of cancer
cells [5]. Many studies also reported that elevated levels of
MMP-9 are found in colorectal, prostate, brain, lung, breast,
and ovarian cancers [22‒24]. MMP-9 is directly involved in the
degradation of the collagen IV component of the basement
membrane, which plays a crucial role in cancer invasiveness [3].
According to our results, MECF suppressed TNF-a-induced
MMP-9 expression and activity in MDA-MB-231 cells.
Furthermore, the matrigel assay showed that MECF markedly
downregulated TNF-a-induced invasion of the MDA-MB-
231 cells, which suggests that MECF is a promising strategy for
regulating cancer invasion. Additionally, the activity of MMP-9
is traditionally postulated to be governed by tissue inhibitors of
metalloproteinases (TIMPs), which are complex proteins
composed of four proteins ranging in molecular size from 21 to
28 kDa [25]. Therefore, it is essential to understand whether
TIMPs may be involved in MECF-induced MMP-9 regulation.
In past decades, numerous in vivo and in vitro studies indi-
cated that the pleiotropic NF-kB plays a signiﬁcant role in
various types of biological activities including carcinogenesis,
adhesion, invasion, and cell survival [26]. In particular, NF-kB
regulates the expression of inﬂammatory and carcinogenic
genes including MMP-9 in different types of cancers such as
breast, lung, colon, hepatocellular, prostate and ovarian carci-
nomas [24]. Therefore, targeting NF-kB activity is a possible
method to attenuate cancer invasion by suppressing MMP-9
expression. Accordingly, recent studies have focused on mac-
roalgae- and plants-derived natural compounds that suppress
MMP-9 expression via the NF-kB signaling pathway [15,27]. The
results from this present study demonstrated that MECF
inhibited the invasiveness of MDA-MB-231 cells by
downregulating MMP-9, which resulted from the suppression
of NF-kB activity.
In conclusion, we investigated the anti-invasive property of
MECF in MDA-MB-231 cells, through its suppression of NF-
kB-dependent MMP-9 activity. Our results indicate that MECF
might be a promising therapeutic candidate for the inhibition of
cancer invasiveness through the suppression of NF-kB and the
downstream target, MMP-9.
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